$ cat ./records/launched-grand-challenges-china-funding-chinese-scientists-to-sol-2015.txt
Launched Grand Challenges China — funding Chinese scientists to solve global health problems
[RECORD.TXT] · cat --full
The Gates Foundation extended its Grand Challenges program into China through a dedicated Grand Challenges China initiative, awarding competitive grants to Chinese researchers working on innovations in vaccines, diagnostics, disease vectors, and agricultural productivity for the developing world. The program recognized China's rapidly growing scientific research capacity and aimed to channel it toward neglected global health problems. Chinese grantees worked on projects including room-temperature-stable vaccines, low-cost malaria diagnostics, and drought-resilient crops for sub-Saharan Africa.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates and Obama met on sidelines of COP21 Paris climate conference
Next →
Awarded India's Padma Bhushan for philanthropic work across the country
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.